According to a recent study, children and adolescents with atopic dermatitis (AD) are more likely to develop multiple non-atopic comorbidities than those without AD.
Pruritus, pain are main drivers of AD impact and HRQoL, according to study
According to a recent study, pain and pruritus are the main contributors to atopic dermatitis (AD) burden and poor health-related quality of life (HRQoL).
Study shows patch tests for allergic contact dermatitis still effective in AD patients on dupilumab
According to a recent study, the use of dupilumab in patients with atopic dermatitis (AD) did not significantly affect the results of patch tests for allergic contact dermatitis.
Colloidal oatmeal as efficacious as barrier cream in Black children with AD
According to a recent study, colloidal oatmeal 1% is efficacious in treating mild-to-moderate atopic dermatitis (AD) in Black children.
EADV 2023 Day 3 Evening: Molecular Signature of Chronic Hand Eczema
Dr. Vimal Prajapati reports live from the 2023 EADV Congress in Berlin and discusses the common molecular signature of chronic hand eczema.
EADV 2023 Day 2 Afternoon: Treating Severe Atopic Dermatitis with Tapinarof 1% Cream
Dr. Vimal Prajapati reports live from the 2023 EADV Congress in Berlin and discusses tapinarof 1% cream for treating severe atopic dermatitis
EADV 2023 Day 1 Evening: Late Breakers in Atopic Dermatitis
Dr. Mark Kirchhof reports live from the 2023 EADV Congress in Berlin and discusses late breaker presentations around atopic dermatitis and prurigo nodularis.
Dupilumab lowers IgE levels in AD patients regardless of dosing interval
According to a recent study, dupilumab successfully decreases immunoglobulin E (IgE) serum levels in atopic dermatitis (AD) patients regardless of dosing interval.
Maternal high protein diet linked to AD during first year of life
According to a new study, a maternal high protein diet may be a risk factor for infantile atopic dermatitis (AD) during the first year of life.
QoL impairment and worse symptoms in PsO, AD linked to differing views on disease severity
According to a new study, psoriasis and atopic dermatitis (AD) patients may have differing views on disease severity, a phenomenon known as discordant severity grading. This phenomenon has been linked to higher symptom expression and greater quality of life (QoL) impairment.
HealthMinute.TV 